Pharmaceuticals, Biotechnology and Life Sciences
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#AI— Systems Oncology, LLC (“SO”) and The Pritzker Organization, LLC (“TPO”) announced today that Pritzker Family Business Interests…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company developing oral small molecules for oncology and inflammatory…
– First Five Patients Enrolled into Study, Reaching 25% Completion of Targeted Enrollment – CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp.…
CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #AMD—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies…
CVL-231 has the potential to be the first novel mechanism of action in schizophrenia in over two decades BOSTON–(BUSINESS WIRE)–Cerevel…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, a biotechnology company focused on drugging the human immune synapse to treat human diseases, today announced…
Top line results are expected to be available in February 2020 GAINESVILLE, Fla.–(BUSINESS WIRE)–Cyclo Therapeutics, Inc. (OTCQB: CTDH), formerly CTD…
More than $2.9 million in funding will support clinical trials to study virtual reality platforms as a therapeutic alternative for…
LONDON–(BUSINESS WIRE)–#MarketIntelligence–SpendEdge, a global procurement market intelligence firm, has announced the release of its Global Pharmaceutical Excipients Market – Procurement…
WESTPORT, Conn.–(BUSINESS WIRE)–Intensity Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary intratumoral immunotherapy products to kill tumors and increase immune…